Diseases · Entity Annotation Prototype (beta)

40articles mentioning diseases

119disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: TNBC ×

TNBC

This disease is selected. Its supporting articles are shown below.

TNBC40

Articles mentioning TNBC

40 articles · page 4 of 4

468 Pathological complete response with pembrolizumab in combination with chemotherapy for neoadjuvant treatment of early triple negative breast cancer: a single-center prospective study from Bangladesh

jitc · abstract · 2025-11-04 · 1 matching annotations

76.0%

breast cancer TNBC Pembrolizumab Anthracycline Cyclophosphamide Paclitaxel Carboplatin chemotherapy

…Background Triple negative breast cancer is the kind of breast cancer that does not have any receptors w…

52 A novel approach for the prediction of resistance to immune checkpoint inhibitors (ICI), based on tolerogenic dendritic cell mediators (TDCMs)

jitc · abstract · 2025-11-04 · 1 matching annotations

83.5%

HNSCC Melanoma NSCLC SCLC GBM CA HCC CRC RCC TNBC+2 more

… IL-27, NO, VIP, VDR, TRAIL, and the Ca types were NSCLC, SCLC, HNSCC, Melanoma, GBM, Pancreatic, Bladder, Gastric, Prostate, Breast,…

669 Characterization of matched tumor and peripheral blood revealed temra T cells play a central role in eliciting systemic immune responses in TNBC patients treated with anti-PD1 and radiation

jitc · abstract · 2025-11-04 · 1 matching annotations

78.1%

Triple-negative breast cancer TNBC NCT03366844 ICIs Immune checkpoint inhibitors radiation therapy

…Background Triple-negative breast cancer (TNBC) is an aggressive subtype, comprising 10-15% of breast ca…

905 Regulation of radiation-induced innate immune signaling in patient-derived triple-negative breast cancer organoids

jitc · abstract · 2025-11-04 · 1 matching annotations

77.3%

triple negative breast cancer TNBC#2 TNBC TNBC#1 pembrolizumab DOD W81XWH-21-2-0034 Burroughs Wellcome Physician-Scientist Award BCRF 24-053

…response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer. Cancer Cell. 2024;42:70–84.Lee KM, et al. Epigenetic repressio…

Browse diseases

TNBC

Articles mentioning TNBC

468 Pathological complete response with pembrolizumab in combination with chemotherapy for neoadjuvant treatment of early triple negative breast cancer: a single-center prospective study from Bangladesh

52 A novel approach for the prediction of resistance to immune checkpoint inhibitors (ICI), based on tolerogenic dendritic cell mediators (TDCMs)

669 Characterization of matched tumor and peripheral blood revealed temra T cells play a central role in eliciting systemic immune responses in TNBC patients treated with anti-PD1 and radiation

905 Regulation of radiation-induced innate immune signaling in patient-derived triple-negative breast cancer organoids